{"SPADE_UN_03971": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2008/0249022 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2008_0249022_A1", "Patent Type": "Patent Application", "Publication Date": "2008-10-9", "Family Info": "CA2574959A1,CN101018563A,EP1621205A1,EP1784206A2,EP2221061A1,US7803756,US20110053835,WO2006011792A2,WO2006011792A3", "Patent Title": "Antimicrobial Peptides Derived From Cap18.", "Abstract": "The present invention relates to a group of peptidic compounds which have antimicrobial activity. The compounds also have affinity for toxins and especially for bacterial toxins, such as lipopolysaccharide or lipoteichoic acid. The compounds can be used to manufacture medicaments useful for the treatment of bacterial or fungal infections. The medicaments may be administered systemically or locally."}], "Sequence Information": {"SPADE ID": "SPADE_UN_03971", "Sequence": "RPLR", "Sequence Length": 4, "Peptide Name": "Sequence 6 from Patent US 20080249022", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antibacterial", "Antifungal"], "Frequent Amino Acids": "RLP", "Absent Amino Acids": "ACDEFGHIKMNOQSTUVWY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 2, "Positive Residues": 2, "Negative Residues": 0, "Mass": 540.66, "PI": 12.0, "Net Charge": 2, "Hydrophobicity": -1.7, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02228", "Similarity": 1.0, "Sequence": "HSSGYTRPLRKPSRPIFIRPIGCDVCYGIPSSTARLCCFRYGDCCHL"}, {"SPADE_ID": "SPADE_N_02514", "Similarity": 1.0, "Sequence": "RRLRPRRPRLPRPRPRPRPRPRSLPLPRPKPRPIPRPLPLPRPRPKPIPRPLPLPRPRPRRIPRPLPLPRPRPRPIPRPLPLPQPQPSPIPRPL"}, {"SPADE_ID": "SPADE_N_05739", "Similarity": 1.0, "Sequence": "RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPL"}]}}}